Term
|
Definition
| Programmed or physiologic cell death caused by the cell itself when its growth becomes abnormal. |
|
|
Term
|
Definition
| A growth that does not endanger life or health. |
|
|
Term
|
Definition
| Use of biologic response modifiers to treat cancer. |
|
|
Term
|
Definition
| A syndrome characterized by anorexia, weight loss, anemia, asthenia (weakness), and early satiety (feeling of being full). |
|
|
Term
|
Definition
| Chemicals or processes that, when combined with genetic traits and in interaction with one another, cause cancer. |
|
|
Term
|
Definition
| Treatment to combat cancer that involves drugs taken orally, intravenously, intrathecally, or by injection, which kill both normal and cancerous cells. |
|
|
Term
|
Definition
| Nontraditional medicine that is used in combination with conventional medicine. |
|
|
Term
|
Definition
| To reduce the size of a solid tumor. |
|
|
Term
|
Definition
| Damage that occurs when a chemotherapeutic drug leaks into the soft tissue surrounding the infusion site. |
|
|
Term
|
Definition
| A higher than normal leukocyte count. |
|
|
Term
|
Definition
| A lower than normal white blood cell count. |
|
|
Term
|
Definition
| The progressive growth of a tumor that will, if not checked by treatment, result in death. |
|
|
Term
|
Definition
| The spread of cancer cells to other sites in the body. |
|
|
Term
|
Definition
| A decreased production of blood cells in the bone marrow. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| A decreased number of neutrophils. |
|
|
Term
|
Definition
| A portion of the DNA that is altered and, when duplicated, causes uncontrolled cellular division. |
|
|
Term
|
Definition
| A decreased number of blood cell components. |
|
|
Term
|
Definition
| Pain that feels as if it is in an amputated extremity and is caused by trauma to the nerves in the area of the amputation. |
|
|
Term
|
Definition
| The use of many drugs at one time to treat multiple health conditions. |
|
|
Term
|
Definition
| A gene that regulates cellular growth and development but can become an oncogene, capable of causing cancerous growth. |
|
|
Term
|
Definition
| A plan of action for chemotherapy that is based on the type of cancer, its stage, and the particular cell type. |
|
|
Term
|
Definition
| Cancer treatment using unstable isotopes that release varying levels of energy to cause breaks in the DNA molecule and thereby destroy cells. |
|
|
Term
|
Definition
| Also called second malignant neoplasm (SMN) and most commonly solid tumors, these occur after the primary cancer and treatment but are of a different histologic type. |
|
|
Term
|
Definition
| The process of Labeling the type of cancer cells, severity and spread, to determine the recommended treatment. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Genetic material that controls the growth of cells, decreasing the effects of oncogenes. |
|
|
